EDIT:NASDAQ
Editas Medicine Inc
US$ 2.17
arrow_upward
+1.40%(+0.030) Siku 1
13 Nov, 16:00:01 GMT -5 · USD
search
Alama zote
| Alama | Bei | Tofauti | Tofauti ya asilimia |
|---|
insights_autoInatayarisha maarifa maarufu ya EDIT...
Fungua
US$ 2.14
Juu
US$ 2.21
Chini
US$ 2.01
Mtaji wa soko
334.92M
Wastani wa kiasi cha mauzo
2.42M
Kiasi cha mauzo ya hisa
2.79M
Juu kwa wiki 52
US$ 3.94
Chini kwa wiki 52
US$ 1.66
EPS
-US$ 0.62
Beta
2.09
Hisa za wawekezaji
154.34M
Idadi ya wafanyakazi
87
Fungua
US$ 2.14
Juu
US$ 2.21
Chini
US$ 2.01
Mtaji wa soko
334.92M
Wastani wa kiasi cha mauzo
2.42M
Kiasi cha mauzo ya hisa
2.79M
Juu kwa wiki 52
US$ 3.94
Chini kwa wiki 52
US$ 1.66
EPS
-US$ 0.62
Beta
2.09
Hisa za wawekezaji
154.34M
Idadi ya wafanyakazi
87
Habari
Kutoka kwenye vyanzo vya wavuti na washirika wa habari
TradingKey
·
saa 6 zilizopita
S&P 500 Forecast: Index Poised to Retest Record High in November After 500-Point Pullback, Biggest Daily Gain in Nearly Seven Months
Foreign Policy Journal
·
saa 5 zilizopita
Dow Jones Industrial Average (DJIA) Stays Green While Nasdaq Tumbles Nearly 1% In Sharp Rotation Trade
24/7 Wall St.
·
saa 9 zilizopita
He Thinks His $200,000 S&P 500 401(k) Spreads His AI Risk. Two Alphabet Share Classes Put $10,380 in One Company. A 20% Drop Could Cost Him $2,076
Traders Union
·
saa 13 zilizopita
Michael Kantro: Institutional investors focus on stock picking as S&P 500 targets have lost relevance
Wasifu
Editas Medicine, Inc., is a clinical-stage biotechnology company that is developing therapies for rare diseases using CRISPR gene editing technology. Editas Medicine headquarters is located in Cambridge, Massachusetts with additional facilities in Boulder, Colorado. Wikipedia
Kuhusu Editas Medicine Inc
Afisa Mkuu Mtendaji (CEO)-
Wafanyakazi87
LilianzishwaNov 2013
Makao makuu-
SektaHealth Care
Sekta-
Tovutieditasmedicine.com